SanBio Company: AKUUGO® commercial launch drives progress, but losses persist amid ongoing R&D and expansion
AKUUGO® launched commercially in Japan after NHI listing, with global expansion and new indications in progress. Operating and net losses narrowed year-over-year, while cash reserves declined due to R&D and regulatory costs. Equity ratio remains strong at 84%.Original document: SanBio Co., Ltd. [45…